Epstein-Barr virus directed screening for nasopharyngeal carcinoma in individuals with positive family history: A systematic review

This publication has 29 references indexed in Scilit:

• An International Collaboration to Harmonize the Quantitative Plasma Epstein-Barr Virus DNA Assay for Future Biomarker-Guided Trials in Nasopharyngeal Carcinoma
  Clinical Cancer Research, 2013
• Seroreactivity against Epstein–Barr virus (EBV) among first‐degree relatives of sporadic EBV‐associated nasopharyngeal carcinoma in Indonesia
  Journal of Medical Virology, 2012
• Elevated Epstein–Barr virus seroreactivity among unaffected members of families with nasopharyngeal carcinoma
  Journal of Medical Virology, 2011
• Prognostic Utility of Anti-EBV Antibody Testing for Defining NPC Risk among Individuals from High-Risk NPC Families
  Clinical Cancer Research, 2011
• Familial Tendency and Risk of Nasopharyngeal Carcinoma in Taiwan: Effects of Covariates on Risk
  American Journal of Epidemiology, 2010
• A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci
  Nature Genetics, 2010
• Outcomes of nasopharyngeal carcinoma screening for high risk family members in Hong Kong
  Familial Cancer, 2009
• Distribution of Epstein‐Barr viral load in serum of individuals from nasopharyngeal carcinoma high‐risk families in Taiwan
  International Journal of Cancer, 2005
• Epstein‐Barr virus seroreactivity among unaffected individuals within high‐risk nasopharyngeal carcinoma families in Taiwan
  International Journal of Cancer, 2004
• Measuring inconsistency in meta-analyses
  BMJ, 2003